GSA Capital Partners »

Acasti Pharma shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $48k 14k 3.48

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
Vanguard Group
ADAR1 Capital Management
Stonepine Capital Management
Renaissance Technologies
Citadel Advisors
Millington Financial Advisors
GSA Capital Partners
Stratos Wealth Partners
National Bank Of Canada /fi/
Tower Research Capital
Royal Bank of Canada
Activest Wealth Management
SBI Securities

View all funds holding Acasti Pharma